Patents by Inventor Aishwarya SRIDHARAN

Aishwarya SRIDHARAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of polyamines in compositions and methods for inducing or promoting skin darkening and regulating melanogenesis
    Patent number: 11219588
    Abstract: The present disclosure provides a method of inducing or promoting darkening of the skin and/or melanogenesis, a method of treating a skin condition or disorder, in particular hypopigmentation, comprising administration of a polycationic aliphatic amine, wherein said polycationic aliphatic amine preferably is putrescine, spermidine and spermine. The invention further includes corresponding methods of reducing or preventing darkening of skin and/or melanogenesis, or related methods of treating a skin condition or disorder, comprising administration of at least an inhibitor of polycationic aliphatic amine transport or synthesis, wherein said inhibitor is preferably trimer44NMe or difluoromethylornithine (DFMO) respectively.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: January 11, 2022
    Assignee: Agency for Science, Technology and Research
    Inventors: Leah Vardy, Aishwarya Sridharan
  • Use of Polyamines in Compositions and Methods for Inducing or Promoting Skin Darkening and Regulating Melanogenesis
    Publication number: 20190216702
    Abstract: The present disclosure provides a method of inducing or promoting darkening of the skin and/or melanogenesis, a method of treating a skin condition or disorder, in particular hypopigmentation, comprising administration of a polycationic aliphatic amine, wherein said polycationic aliphatic amine preferably is putrescine, spermidine and spermine. The invention further includes corresponding methods of reducing or preventing darkening of skin and/or melanogenesis, or related methods of treating a skin condition or disorder, comprising administration of at least an inhibitor of polycationic aliphatic amine transport or synthesis, wherein said inhibitor is preferably trimer44NMe or difluoromethylornithine (DFMO) respectively.
    Type: Application
    Filed: September 8, 2017
    Publication date: July 18, 2019
    Inventors: Leah VARDY, Aishwarya SRIDHARAN